Neugaba M 75 Capsule

16% OFF
16% OFF

Original price was: ₹304.69.Current price is: ₹255.00.

Neugaba M 75 Capsule
Salt Composition: Methylcobalamin (750mcg) + Pregabalin (75mg)
Marketer: Sun Pharmaceutical Industries Ltd

15.0 capsules in 1 strip

 

 

Buy Now
Category:

Description

Neugaba M 75 Capsule is a prescription medicine used for the treatment of neuropathic pain and nerve-related disorders. It combines two active ingredients:

  • Methylcobalamin (750mcg): A form of vitamin B12 that helps in nerve repair and regeneration, improving nerve function and reducing nerve damage.

  • Pregabalin (75mg): An anticonvulsant and neuropathic pain agent that reduces nerve pain by calming overactive nerve signals.

Together, they help relieve pain, tingling, numbness, and burning sensations caused by diabetic neuropathy, peripheral neuropathy, and other nerve disorders.

Uses:

  • Management of neuropathic pain (diabetic neuropathy, post-herpetic neuralgia)

  • Peripheral neuropathy symptoms (tingling, numbness, burning pain)

  • Nerve regeneration and vitamin B12 supplementation in deficiency-related neuropathy

How to Use:

  • Take the capsule as prescribed by your doctor, usually once or twice daily.

  • Swallow whole with water; can be taken with or without food.

  • Do not crush or chew the capsule.

Dosage:

  • Dosage is individualized based on severity of symptoms and patient response.

  • Do not adjust the dose without consulting your doctor.

Precautions:

  • Inform your doctor if you have kidney or liver problems.

  • Use with caution in patients with a history of drug allergy or epilepsy.

  • Avoid alcohol while taking this medication as it may increase drowsiness.

  • Consult your doctor if pregnant or breastfeeding.

Possible Side Effects:

  • Dizziness, drowsiness, or fatigue

  • Nausea, vomiting, or constipation

  • Swelling of hands, feet, or ankles (edema)

  • Headache or blurred vision

  • Rarely, allergic reactions or mood changes

Leave a Reply

Your email address will not be published. Required fields are marked *